View by Specialty

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

Hematology/Oncology News

SPONSORED CONTENT
Save
SPONSORED CONTENT
September 10, 2024
2 min watch
Save

VIDEO: Potential of AI in breast cancer diagnostics

VIDEO: Potential of AI in breast cancer diagnostics

In this video interview, Sara M. Tolaney, MD, MPH, highlights the integration of artificial intelligence in radiologic reads to assist technicians in detecting abnormalities during breast cancer screenings.

SPONSORED CONTENT
September 10, 2024
1 min watch
Save

VIDEO: Low-dose tamoxifen reduces toxicity with ‘very robust efficacy’

VIDEO: Low-dose tamoxifen reduces toxicity with ‘very robust efficacy’

In this video interview, Sara M. Tolaney, MD, MPH, highlights the efficacy of low-dose tamoxifen used for breast cancer prevention.

Trending

UTI
November 11, 2024
3 min read
Save

WikiGuidelines group publishes first new UTI guidance in 14 years

SPONSORED CONTENT
September 10, 2024
3 min watch
Save

VIDEO: How providers can ‘do better’ to improve access to care for breast cancer patients

VIDEO: How providers can ‘do better’ to improve access to care for breast cancer patients

In this video interview, Sara M. Tolaney, MD, MPH, discusses the need to address disparities among patients with breast cancer.

SPONSORED CONTENT
September 10, 2024
2 min read
Save

Mindful breathing significantly reduces pain intensity among people with cancer

Mindful breathing significantly reduces pain intensity among people with cancer

A 20-minute mindful breathing session rapidly reduced pain intensity and anxiety among people with cancer, according to results of a randomized controlled study.

SPONSORED CONTENT
September 10, 2024
2 min read
Save

Severe toxicity risk from radiotherapy ‘may not be trivial’ in systemic sclerosis

Severe toxicity risk from radiotherapy ‘may not be trivial’ in systemic sclerosis

Radiotherapy poses no significant risks for worsening disease in patients with systemic sclerosis, but entails “variable risk” for both acute and late toxicities, according to data published in The Journal of Rheumatology.

SPONSORED CONTENT
September 10, 2024
3 min read
Save

Despite benefits, many patients with leukemia, lymphoma do not undergo IgG tests

Despite benefits, many patients with leukemia, lymphoma do not undergo IgG tests

Many patients with chronic lymphocytic leukemia or non-Hodgkin lymphoma do not undergo immunoglobulin G testing despite its potential to reduce likelihood of severe infections.

SPONSORED CONTENT
September 09, 2024
2 min read
Save

Women 8% less likely than men to receive a liver transplant, possibly due to candidate size

Women 8% less likely than men to receive a liver transplant, possibly due to candidate size

Women with hepatocellular carcinoma were less likely to receive a liver transplant and more likely to die or be removed from the waitlist vs. men, underscoring the need for changes to allocation policies, according to researchers.

SPONSORED CONTENT
September 09, 2024
2 min read
Save

Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’

Ivonescimab extends PFS vs. pembrolizumab in advanced NSCLC, may be ‘a new standard’

Ivonescimab significantly improved PFS compared with pembrolizumab as first-line treatment of PD-L1-positive advanced non-small cell lung cancer, according to results of the HARMONi-2 trial.

SPONSORED CONTENT
September 09, 2024
3 min read
Save

Perioperative nivolumab improves outcomes in resectable NSCLC

Perioperative nivolumab improves outcomes in resectable NSCLC

Immunotherapy before and after surgery significantly improved EFS compared with neoadjuvant immunotherapy only for patients with resectable non-small cell lung cancer, according to a comparison of results from two randomized phase 3 trials.

SPONSORED CONTENT
September 09, 2024
2 min read
Save

Despite progress, barriers to lung cancer biomarker testing persist

Despite progress, barriers to lung cancer biomarker testing persist

Acceptance and utilization of lung cancer biomarker testing has increased in the past 6 years, but key barriers persist, according to survey results.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails